EXTENSIVELY DRUG-RESISTANT TUBERCULOSIS
Clinical trials for EXTENSIVELY DRUG-RESISTANT TUBERCULOSIS explained in plain language.
Never miss a new study
Get alerted when new EXTENSIVELY DRUG-RESISTANT TUBERCULOSIS trials appear
Sign up with your email to follow new studies for EXTENSIVELY DRUG-RESISTANT TUBERCULOSIS, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New hope for kids with Drug-Resistant TB: bedaquiline trial launches
Disease control Recruiting nowThis study tests a drug called bedaquiline in children and teens (0 months to under 18 years) with multidrug-resistant tuberculosis (MDR-TB), a lung infection that does not respond to standard antibiotics. About 60 participants will receive bedaquiline along with other TB medicat…
Matched conditions: EXTENSIVELY DRUG-RESISTANT TUBERCULOSIS
Phase: PHASE2 • Sponsor: Janssen Research & Development, LLC • Aim: Disease control
Last updated Jul 08, 2026 00:00 UTC
-
TB study aims to unlock secrets of the disease
Knowledge-focused Recruiting nowThis study follows 150 people with active or latent tuberculosis (TB) to collect blood, sputum, and tissue samples. The goal is to better understand how TB behaves in the body and how the immune system responds. Participants receive standard TB treatment as part of the study, but…
Matched conditions: EXTENSIVELY DRUG-RESISTANT TUBERCULOSIS
Sponsor: National Institute of Allergy and Infectious Diseases (NIAID) • Aim: Knowledge-focused
Last updated Aug 09, 2026 00:00 UTC